Q1 2025 Holdings
Filed 2025-04-29 | 666 holdings | $4.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Humacyte Inc(HUMA) | Common Stock | 44486Q103 | $5.6K | 3,295 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | Common Stock | 46333X108 | $5.8K | 3,971 | 0.0% |
| Coinbase Global Inc(COIN) | Common Stock | 19260Q107 | $5.9K | 34 | 0.0% |
| Terns Pharmaceuticals Inc(TERN) | Common Stock | 880881107 | $6.0K | 2,174 | 0.0% |
| Amylyx Pharmaceuticals Inc(AMLX) | Common Stock | 03237H101 | $6.0K | 1,700 | 0.0% |
| CBL & Associates Properties In(CBL) | REIT | 124830878 | $6.1K | 231 | 0.0% |
| Atea Pharmaceuticals Inc(AVIR) | Common Stock | 04683R106 | $6.3K | 2,096 | 0.0% |
| 2seventy bio Inc(TSVT*) | Common Stock | 901384107 | $6.3K | 1,280 | 0.0% |
| Acelyrin Inc | Common Stock | 00445A100 | $6.3K | 2,569 | 0.0% |
| Personalis Inc(PSNL) | Common Stock | 71535D106 | $6.4K | 1,809 | 0.0% |
| Aquestive Therapeutics Inc(AQST) | Common Stock | 03843E104 | $6.6K | 2,262 | 0.0% |
| Tectonic Therapeutic Inc(TECX) | Common Stock | 878972108 | $6.7K | 377 | 0.0% |
| Prime Medicine Inc(PRME) | Common Stock | 74168J101 | $6.7K | 3,358 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | Common Stock | 921659108 | $6.9K | 1,493 | 0.0% |
| Alpha Teknova Inc(TKNO) | Common Stock | 02080L102 | $7.1K | 1,365 | 0.0% |
| Alumis Inc(ALMS) | Common Stock | 022307102 | $7.2K | 1,172 | 0.0% |
| Esperion Therapeutics Inc(ESPR) | Common Stock | 29664W105 | $7.3K | 5,045 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | Common Stock | 61225M102 | $7.3K | 1,572 | 0.0% |
| Taysha Gene Therapies Inc(TSHA) | Common Stock | 877619106 | $7.3K | 5,248 | 0.0% |
| Arcturus Therapeutics Holdings(ARCT) | Common Stock | 03969T109 | $7.3K | 693 | 0.0% |
| MaxCyte Inc(MXCT) | Common Stock | 57777K106 | $7.4K | 2,701 | 0.0% |
| Absci Corp(ABSI) | Common Stock | 00091E109 | $7.4K | 2,941 | 0.0% |
| OmniAb Inc(OABI) | Common Stock | 68218J103 | $7.4K | 3,099 | 0.0% |
| Aura Biosciences Inc(AURA) | Common Stock | 05153U107 | $7.5K | 1,279 | 0.0% |
| Hudson Pacific Properties Inc | REIT | 444097109 | $7.5K | 2,541 | 0.0% |
| Diversified Healthcare Trust(DHC) | REIT | 25525P107 | $7.6K | 3,159 | 0.0% |
| Astria Therapeutics Inc(CATBUSD) | Common Stock | 04635X102 | $7.7K | 1,444 | 0.0% |
| Allogene Therapeutics Inc(ALLO) | Common Stock | 019770106 | $7.8K | 5,368 | 0.0% |
| Autolus Therapeutics PLC(AUTL) | ADR | 05280R100 | $7.9K | 5,113 | 0.0% |
| Pacific Biosciences of Califor(PACB) | Common Stock | 69404D108 | $8.0K | 6,791 | 0.0% |
| Maravai LifeSciences Holdings(MRVI) | Common Stock | 56600D107 | $8.0K | 3,631 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGL) | Common Stock | 766559702 | $8.1K | 451 | 0.0% |
| One Liberty Properties Inc(OLP) | REIT | 682406103 | $8.4K | 321 | 0.0% |
| Cartesian Therapeutics Inc(RNAC) | Common Stock | 816212302 | $8.6K | 650 | 0.0% |
| Entrada Therapeutics Inc(TRDA) | Common Stock | 29384C108 | $8.7K | 958 | 0.0% |
| Galapagos NV(GLPG) | ADR | 36315X101 | $9.0K | 357 | 0.0% |
| Stoke Therapeutics Inc(STOK) | Common Stock | 86150R107 | $9.0K | 1,355 | 0.0% |
| Saul Centers Inc(BFS) | REIT | 804395101 | $9.0K | 250 | 0.0% |
| Regenxbio Inc(RGNX) | Common Stock | 75901B107 | $9.1K | 1,269 | 0.0% |
| Altimmune Inc(ALT) | Common Stock | 02155H200 | $9.1K | 1,821 | 0.0% |
| Oruka Therapeutics Inc(ORKA) | Common Stock | 687604108 | $9.2K | 896 | 0.0% |
| Alexander's Inc(ALX) | REIT | 014752109 | $9.2K | 44 | 0.0% |
| Rapport Therapeutics Inc(RAPP) | Common Stock | 75383L102 | $9.4K | 936 | 0.0% |
| EyePoint Pharmaceuticals Inc(EYPT) | Common Stock | 30233G209 | $9.5K | 1,747 | 0.0% |
| Bicycle Therapeutics PLC(BCYC) | ADR | 088786108 | $9.6K | 1,126 | 0.0% |
| Farmland Partners Inc(FPI) | REIT | 31154R109 | $9.6K | 858 | 0.0% |
| Community Healthcare Trust Inc(CHCT) | REIT | 20369C106 | $9.6K | 527 | 0.0% |
| CorMedix Inc(CRMD) | Common Stock | 21900C308 | $9.6K | 1,554 | 0.0% |
| Sana Biotechnology Inc(SANA) | Common Stock | 799566104 | $9.6K | 5,716 | 0.0% |
| Verve Therapeutics Inc | Common Stock | 92539P101 | $9.9K | 2,167 | 0.0% |